Interest in services among prostate cancer patients receiving androgen deprivation therapy

被引:26
|
作者
Shapiro, PJ
Coyne, JC
Kruus, LK
Palmer, SC
Vaughn, DJ
Malkowicz, SB
机构
[1] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Temple Univ, Sch Med, Dept Psychiat, Philadelphia, PA 19122 USA
[4] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Dept Urol, Philadelphia, PA 19104 USA
关键词
D O I
10.1002/pon.769
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Treatment side effects and decreased quality of life associated with androgen deprivation therapy (ADT) suggest the need for supportive services for prostate cancer (PC) patients receiving ADT. Nonetheless, uptake of services is low, suggesting that PC patients' preferences are not being addressed. We examined interest in supportive services and predictors of interest among 118 PC patients receiving ADT. Overall interest in services was associated with lower quality of life (p = 0.01). The majority of participants expressed interest in informational services (70%), with a minority (22%) expressing interest in psychosocial services. Interest in psychosocial services was associated with younger age (p = 0.02), and shorter duration of ADT (p < 0.04), but was unrelated to psychological distress or social support. Although most men (68%) reported that they would prefer not to take medication for depression, 75% would do so if advised by their physician. Overall, results suggest that PC patients on ADT prefer individualized informational support. Substantial interest (61%) in Oncolink, an internet-based informational resource, suggests the Internet may provide an acceptable mode of service delivery. Health care providers should consider integrating increased informational support into routine care and, more generally, consider patient preferences in prioritizing and designing support services. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:512 / 525
页数:14
相关论文
共 50 条
  • [1] Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy
    Cooperberg, Matthew R.
    Hinotsu, Shiro
    Namiki, Mikio
    Ito, Kazuto
    Broering, Jeanette
    Carroll, Peter R.
    Akaza, Hideyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4306 - 4313
  • [2] Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy
    Janssen, Stefan
    Karstens, Johann H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (09) : 526 - 528
  • [3] Nutritional program among patients with prostate cancer receiving androgen deprivation therapy (ADT)
    Lages, Paulo Sergio
    Pivato de Almeida, Daniel Vargas
    Bergerot, Cristiane Decat
    Bergerot, Paulo Gustavo
    Barbosa, Michelle
    Dutra, Camila Rosa
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] BONE HEALTH IN THE PROSTATE CANCER PATIENTS RECEIVING ANDROGEN DEPRIVATION THERAPY
    Park, Nam Cheol
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 45 - 45
  • [5] Quality of sleep in patients receiving androgen deprivation therapy for prostate cancer
    Koskderelioglu, Asli
    Gedizlioglu, Muhtesem
    Ceylan, Yasin
    Gunlusoy, Bulent
    Kahyaoglu, Nilden
    NEUROLOGICAL SCIENCES, 2017, 38 (08) : 1445 - 1451
  • [6] Quality of sleep in patients receiving androgen deprivation therapy for prostate cancer
    Asli Koskderelioglu
    Muhtesem Gedizlioglu
    Yasin Ceylan
    Bulent Gunlusoy
    Nilden Kahyaoglu
    Neurological Sciences, 2017, 38 : 1445 - 1451
  • [7] Cataracts among elderly prostate cancer patients receiving androgen deprivation therapy (ADT) in the United States
    Beebe-Dimmer, J.
    Schwartz, K. A.
    Cetin, K.
    Morgenstern, H.
    Yee, C.
    Bartoces, M.
    Shahinian, V. B.
    Fryzek, J.
    Acguavella, J. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Predictors of Clinical Metastasis in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
    Abouassaly, Robert
    Paciorek, Alan
    Ryan, Charles J.
    Carroll, Peter R.
    Klein, Eric A.
    CANCER, 2009, 115 (19) : 4470 - 4476
  • [9] Increased Fall Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
    Wu, Fang-Jen
    Sheu, Shiow-Yunn
    Lin, Herng-Ching
    Chung, Shiu-Dong
    UROLOGY, 2016, 95 : 145 - 149
  • [10] Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer
    Tsai, Huei-Ting
    Keating, Nancy L.
    Van den Eeden, Stephen K.
    Haque, Reina
    Cassidy-Bushrow, Andrea E.
    Yood, Marianne Ulcickas
    Smith, Matthew R.
    Potosky, Arnold L.
    JOURNAL OF UROLOGY, 2015, 193 (06): : 1956 - 1962